Safety and Immune Response to an Investigational Dengue Type 2 Vaccine

NCT01073306 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

Dengue Virus

Interventions

BIOLOGICAL: Investigational Vaccine for Dengue Virus Subtype 2
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)